drugset / Trial / NCT00385970

A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer

NCT00385970

RandomizedParallel-groupOpen-labelTreatment

Summary

To compare the efficacy of tegafur/uracil (UFT) plus folinate calcium (leucovorin: LV) administered orally and UFT plus Krestin (PSK) administered orally enrolling patients with pTNM stage IIB or III colorectal cancer as subjects in a multicenter collaborative randomized open-label comparative controlled study and consequently to determine the usefulness of the above regimens as adjuvant therapy after surgery.

Timeline

Start
2006-03
Primary completion
2015-04
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Krestin Unknown 3 g Oral
Comparator Leucovorin Small molecule 75 mg Oral
Background tegafur-uracil Small molecule 300 mg/m2 Oral

Indications